MiMedx Group (MDXG) Cash Flow: Operating & Free Cash Flow

MiMedx Group Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for MiMedx Group, Inc. (MDXG) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Jun 2020	Dec 2018	Dec 2017
Operating Activities
Net Income	48.58	42.00	67.44	-19.95	-12.30	-49.28	-25.58	-29.98	64.73
Depreciation & Amortization	14.88	6.04	3.43	4.05	5.18	6.86	7.59	6.92	5.77
Deferred Income Tax	8.71	12.47	-37.80	0.00	0.00	0.00	0.00	25.54	-26.67
Stock Based Compensation	16.40	16.93	16.96	11.33	14.16	15.36	12.06	14.77	21.20
Change in Working Capital	-22.98	-5.43	-18.42	-8.01	-19.35	-15.69	-20.05	18.60	-0.52
Change in Accounts Receivable	-26.39	-2.55	-12.24	-5.94	-10.62	-3.10	-10.94	0.00	-1.14
Change in Inventory	-1.53	-2.36	-7.84	-1.79	-1.41	-1.26	6.88	-6.52	2.75
Change in Accounts Payable	2.12	-1.41	0.78	0.84	-0.16	0.18	-6.17	6.59	-1.32
Change in Other Working Capital	1.90	-1.22	0.88	-1.12	-7.17	-11.51	-9.83	18.54	-0.81
Other Operating Activities	1.90	7.59	-4.83	-5.30	10.33	12.50	-13.43	-0.05	-1.56
Net Cash from Operating Activities	74.00	66.20	26.78	-17.89	-1.98	-30.26	-39.41	35.80	62.94
Investing Activities
Capital Expenditures	-1.03	-1.68	-1.99	-1.51	-3.22	-4.23	-1.75	-9.42	-5.13
Acquisitions	-3.76	-7.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Investing Activities	0.00	-0.04	-0.17	-1.15	-0.18	-0.33	2.26	0.20	-0.27
Net Cash from Investing Activities	-6.89	-9.58	-2.16	-2.66	-3.40	-4.56	0.50	-9.22	-5.40
Financing Activities
Debt Repayment	-1.00	-51.00	-0.05	-0.04	-0.04	-25.81	70.88	0.00	-0.03
Common Stock Issued	0.00	1.40	1.00	0.65	0.00	0.00	0.00	0.00	0.00
Common Stock Repurchased	-3.12	-2.64	-9.52	-1.19	-4.75	-2.33	-1.47	-12.49	-72.35
Other Financing Activities	-1.29	-1.24	0.00	0.00	1.44	89.71	-6.54	3.56	11.99
Net Cash from Financing Activities	-5.41	-34.20	-8.57	-0.58	-3.35	61.56	62.86	-8.93	-60.39
Summary
Net Change in Cash	61.71	22.42	16.05	-21.13	-8.73	26.74	23.95	17.64	-2.85
Cash at Beginning of Period	104.42	82.00	65.95	87.08	95.81	69.07	45.12	27.48	30.32
Cash at End of Period	166.12	104.42	82.00	65.95	87.08	95.81	69.07	45.12	27.48
Free Cash Flow	72.97	64.52	24.79	-19.41	-5.20	-34.49	-41.16	26.38	57.81
Supplemental Disclosures
Interest Paid	-	2.70	6.03	4.57	4.33	7.46	-	-	-
Income Taxes Paid	-	3.25	-0.55	0.18	0.17	0.21	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About MiMedx Group Cash Flow

What is MiMedx Group's free cash flow?

MiMedx Group generated free cash flow of $72.97M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $74.00M minus $1.03M of capital expenditures. That was up 13.1% from $64.52M a year earlier. Free cash flow equaled 17.4% of revenue.

How much does MiMedx Group spend on capital expenditures?

MiMedx Group spent $1.03M on capital expenditures in fiscal 2025, compared with $1.68M a year earlier. That equals 1.4% of operating cash flow.

Does MiMedx Group pay dividends or buy back shares?

Yes. In fiscal 2025 MiMedx Group returned $3.12M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition